analysis of biomarkers in patients with acute heart failure

analysis of biomarkers in patients with acute heart failure - analysis of biomarkers in patients with acute heart failure

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021859

Enrollment

350

Registered

2016-04-11

Start date

2016-04-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with acute heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients admitted for acute heart failure

Exclusion criteria

Exclusion criteria: acute coronary syndrome infection require left ventricular assist device severe comorbidities (end-stage malignancy, liver cirrhosis, severe lung disease, severe collagen and autoimmune disease) patients who are perceived to be difficult for follow-up *patients with renal dysfunction will be analyzed separately

Design outcomes

Primary

Measure	Time frame
cardiac death, admission for heart failure (90 days, 180days, 1year)	—

Countries

Japan

Contacts

Public ContactKazuya Nagao

Osaka red cross hospital cardiovascular center

nagao@kuhp.kyoto-u.ac.jp06-6774-5111

Outcome results